Trials / Active Not Recruiting
Active Not RecruitingNCT06709144
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer
Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC): a Prospective, Multicenter Randomized Control Clinical Trial
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 896 (estimated)
- Sponsor
- Haixing Ju, MD · Academic / Other
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
The study was conducted on patients with advanced right-sided colon cancer, and the clinical pathological and prognostic data of the patients were compared between the two groups of patients who were randomly divided into those undergoing SMV and SMA left resection, with the aim of resolving the controversy over the left resection boundary of CME/D3 lymph node dissection through this study, and to clarify whether SMA left resection is superior to SMV left resection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | SMA lymph node dissection | The lymph node dissection boundary is on the left side of the superior mesenteric artery (SMA) |
| PROCEDURE | SMV lymph node dissection | The lymph node dissection boundary is on the left side of the superior mesenteric vein (SMV) |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2027-06-30
- Completion
- 2032-06-30
- First posted
- 2024-11-29
- Last updated
- 2024-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06709144. Inclusion in this directory is not an endorsement.